Right Now
Antibiotic resistance testing and diagnostic devices Industry Research
Antimicrobial Susceptibility Testing (AST) is a testing process that uses in vitro methods to evaluate the sensitivity of bacteria to specific antibiotics. Its purpose is to guide clinical rational drug use, control the spread of infection, and monitor drug resistance trends. These devices can determine the resistance status of pathogens to different antibiotics within a few hours to a day through phenotypic observation or genetic testing. They are widely used in hospital microbiology laboratories, disease control centers, and third-party testing agencies, and are core tools in the rational use of antimicrobial drugs and the prevention and control of drug resistance.
The rising prevalence of antibiotic-resistant infections is a major driver for the antibiotic resistance testing and diagnostic devices market. Growing awareness of antimicrobial stewardship, along with government initiatives and funding to combat antimicrobial resistance (AMR), has led to increased adoption of rapid diagnostic tools in clinical settings. The need for early and precise identification of resistant pathogens is also propelling demand for advanced molecular diagnostics and point-of-care testing technologies.
One of the key challenges in this market is the high cost and complexity of implementing advanced diagnostic systems, particularly in low- and middle-income countries. Limited infrastructure, lack of skilled personnel, and slow regulatory approvals hinder widespread adoption. Additionally, diagnostic devices must balance speed, accuracy, and cost-effectiveness, which can be difficult to achieve simultaneously, delaying their routine use in many healthcare facilities.
A significant trend in the antibiotic resistance testing and diagnostic devices market is the shift toward rapid, point-of-care diagnostic solutions. These technologies, including CRISPR-based assays, isothermal amplification methods, and microfluidic platforms, enable clinicians to detect resistant pathogens in real time, improving treatment accuracy and reducing the misuse of antibiotics. The integration of AI and machine learning in diagnostic algorithms is also enhancing the speed and precision of test interpretation.
Another key trend is the growing collaboration between public health organizations, diagnostic companies, and research institutions to develop next-generation resistance testing tools. Initiatives like the WHO's China Antimicrobial Resistance Surveillance System (GLASS) and funding from China health bodies are accelerating innovation and commercialization of novel diagnostics. Additionally, the market is seeing increased investment in multiplex and syndromic testing panels, allowing for the simultaneous detection of multiple resistance markers from a single sample.
According to the new market research report “Antibiotic Resistance Testing and Diagnostic Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”, published by QYResearch, the China Antibiotic resistance testing and diagnostic devices market size is projected to reach USD 0.27 billion by 2031, at a CAGR of 6.0% during the forecast period.
Figure00001. China Antibiotic resistance testing and diagnostic devices Market Size (US$ Million), 2020-2031
Source: QYResearch, "Antibiotic Resistance Testing and Diagnostic Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”
Figure00002. China Antibiotic resistance testing and diagnostic devices Top 10 Players Ranking and Market Share (Ranking is based on the revenue of 2024, continually updated)
Source: QYResearch, "Antibiotic Resistance Testing and Diagnostic Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”
According to QYResearch Top Players Research Center, the global key manufacturers of Antibiotic resistance testing and diagnostic devices include BioMérieux, Danaher, BD, Thermo Fisher Scientific, Zhuhai Deer Biotech, etc. In 2024, the global top five players had a share approximately 81.0% in terms of revenue.
In terms of product application, currently Hospitals is the largest segment, hold a share of 80.5%.
About The Authors
Zhang Xiao - Lead Author
Email: zhangxiao@qyresearch.com
Zhang Xiao is a market senior analyst specializing in medical device, pharma, Lab consumable. Zhang Xiao has 8 years’ experience in medical device and pharma market analysis, and focuses on medical device and consumables (imaging equipment, medical consumables, wearable medical equipment, medical robots, home care equipment, dental equipment, implant equipment, operating room equipment, in vitro diagnostics, etc.) and drugs (API, finished drugs, patented drugs, blood products , vaccines, etc.) . She is engaged in the development of technology and market reports and is also involved in custom projects.
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading China market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are Chinaly recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)
More Posts
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
